Labcyte has wrapped its third round of venture capital with $21 million in new funding. The round was led by Cross Atlantic Partners and included Hambrecht & Quist Capital Management and the Bay Area Equity Fund, a fund managed by JPMorgan, as new investors. Their money will be employed to expand Labcyte's fluid handling business, which is sold to researchers who work with assay plates.
- read this press release for more